Building a Global Data Foundation for Scaling AI
How leading biopharm companies like Bayer are standardizing and integrating data for scaling impactful AI. AI use cases are rippling across commercial biopharma, helping companies…
Pharma
The AI-Powered Revolution in Precision Medicine
Precision medicine is transforming healthcare by replacing the traditional one-size-fits-all approach with personalised care. By integrating a patient’s genetic profile, lifestyle factors, and environmental exposures,…
Transformative technology trends in biotech for 2026 – The Digital and AI Revolution
The biotechnology industry is undergoing a profound digital transformation, with artificial intelligence (AI), cloud computing, and real-time analytics reshaping drug discovery, personalised medicine, and healthcare…
Cold Chain in the Context of Global Warming
Global distribution of life-saving pharmaceuticals is incredibly complex, with several different components from warehouse to final delivery. At each stage, providers must make sure strict…
Has the Life Sciences Industry Finally got to Grips with IDMP?
MAIN5’s Michiel Stam analyses the findings of new research measuring the industry’s readiness for implementing the long-anticipated product data standards and for embracing FAIR data…
The Future of MSL Training – How Digital Technologies Are Shaping Success
Medical Science Liaisons (MSL) play a pivotal role in bridging the gap between pharmaceutical companies and the medical community and are vital to the success…
A New Tool for Fostering GxP System Compliance – Introducing the ‘DAP’
Across pharma Clinical, Regulatory, Quality, and Pharmacovigilance operations, ever more ambitious process digitalisation, and a drive towards “data-first” activity, is heaping the pressure on teams…
Preparing for the Unfathomable: Staying ahead of AI
Generative AI is just one strand of artificial intelligence which is progressing at enormous speed, already pushing the boundaries of deep research, with profound implications…
Managing Patent Cliffs in the Pharmaceutical Industry
For pharmaceutical manufacturers, patents are vital stepping stones that allow companies to recover large investments and fuel future research and breakthroughs. They motivate manufacturers to…
The mixed return on global ambition: are biotechs under-prepared for the dynamic international regulatory climate as they execute their commercialisation plans?
Arriello’s Sam Tomlinson reviews the findings of new US/EU research charting biotech efforts to expand their market globally. The biotech market was estimated to be…